[Errors and hazards in oncology: radiation oncology]

Area of Science:

• Oncology
• Radiation Oncology
• Medical Physics

Background:

• Conventional radiotherapy techniques (e.g., 3-D conformal radiotherapy) have well-documented adverse effects.
• The late toxicity spectrum of advanced radiation techniques, such as intensity modulated radiotherapy (IMRT), requires further investigation.
• IMRT offers potential for improved quality of life by selectively protecting organs like salivary glands.

Purpose of the Study:

• To evaluate the late toxicity profile of intensity modulated radiotherapy (IMRT).
• To assess the benefits and risks of combining IMRT with novel target volume and dose concepts.
• To explore the safety and efficacy of combined-modality treatments including chemotherapy and EGF-receptor antibodies with radiotherapy.

Main Methods:

• Review of existing literature and prospective evaluation of IMRT techniques.
• Analysis of patient outcomes regarding late toxicity and quality of life.
• Investigation of combined cytotoxic drug and radiotherapy protocols.
• Assessment of toxicities associated with EGF-receptor antibodies in conjunction with irradiation.

Main Results:

• IMRT demonstrates potential for improved intermediate-term quality of life due to selective salivary gland protection.
• Combined cytotoxic drugs and radiotherapy can enhance survival in specific high-risk patient groups.
• These combined protocols are associated with significant morbidity and mortality, necessitating specialized care.
• EGF-receptor antibodies have established indications, but their specific toxicities with radiation warrant further study.

Conclusions:

• IMRT is emerging as a standard of care, though further prospective evaluation is essential.
• Combined chemotherapy and radiotherapy require expert management due to high associated risks.
• Careful monitoring and prospective studies are crucial for understanding and managing toxicities from novel treatments like EGF-receptor antibodies with radiation.